Danaher Corp DHR

Morningstar Rating
$214.06 +2.30 (1.09%)
View Full Chart

Company Report

Danaher's Momentum May Stall in Late 2026 on Bioprocessing Customer Delays

Through its Danaher Business System, Danaher aims for continuous improvement of its scientific technology portfolio by seeking out attractive markets and then making acquisitions to enter or expand within those fields and also divesting assets that are no longer seen as core, such as the 2023 divestiture of Veralto, its environmental and applied solutions segment. After acquisitions, Danaher aims to accelerate core growth at acquired companies by making research and development and marketing-related investments. It also implements lean manufacturing principles and administrative cost controls to boost operating margins. Overall, we appreciate Danaher's strategic moves, which have pushed it into attractive end markets with strong growth prospects and sticky, recurring revenue streams.

Price vs Fair Value

DHR is trading at a LOCK|f#?jQb premium.
Price
$211.76
Fair Value
LOCK|qw
Uncertainty
LOCK|h$x$?
1-Star Price
LOCK|^.L!Y
5-Star Price
LOCK|g.!!
Economic Moat
LOCK|J@s
Capital Allocation
LOCK|lP#wVN@q

Bulls Say, Bears Say

Bulls

The Danaher Business System focuses on continuous improvement, including the acceleration of core growth and margin expansion through marketing initiatives and innovation, which appears positive for Danaher's long-term prospects.

Bears

Danaher continues to hunt for acquisitions in the life sciences and diagnostics markets, which could constrain ROICs including goodwill if it makes acquisitions at unattractive prices and is not able to integrate them as successfully as in the past.

News

Articles & Videos

Trading Information

Previous Close Price
$211.76
Day Range
$211.98–216.06
52-Week Range
$160.93–242.80
Bid/Ask
$210.07 / $217.00
Shares Outstanding
702.99M
Market Cap
$150.48B
Volume/Avg
4M / 5M

Key Statistics

Price/Earnings (Normalized)
26.08
Price/Sales
6.00
Dividend Yield (Trailing)
0.72%
Dividend Yield (Forward)
0.76%
Dividend Payment Schedule
Jan, Apr, Jul, Oct
Total Yield
2.61%

Company Profile

In 1984, Danaher’s founders transformed a real estate organization into an industrial-focused manufacturing company. Then, through a series of mergers, acquisitions, and divestitures, Danaher now focuses primarily on manufacturing scientific instruments and consumables in the life sciences and diagnostic industries after the late 2023 divestiture of its environmental and applied solutions group, Veralto.
Sector
Healthcare
Industry
Diagnostics & Research
Stock Style Box
Large Value
Total Number of Employees
60,000

Competitors

Valuation

Metric
DHR
MRK
RHHBY
Price/Earnings (Normalized)
26.0816.6718.52
Price/Book Value
2.831.948.25
Price/Sales
6.002.774.25
Price/Cash Flow
21.0112.8413.31
Price/Earnings
DHR
MRK
RHHBY

Financial Strength

Metric
DHR
MRK
RHHBY
Quick Ratio
1.030.990.80
Current Ratio
1.651.691.23
Interest Coverage
16.957.2213.49
Quick Ratio
DHR
MRK
RHHBY

Profitability

Metric
DHR
MRK
RHHBY
Return on Assets (Normalized)
5.34%4.75%15.81%
Return on Equity (Normalized)
8.59%8.32%48.77%
Return on Invested Capital (Normalized)
6.45%6.65%23.90%
Return on Assets
DHR
MRK
RHHBY

Diagnostics & Research Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Thermo Fisher Scientific Inc
TMO
LOCK|tnvt<FhLOCK|gZ$241B
Agilent Technologies Inc
A
LOCK|hph@XZ#&LOCK|j#$47B
IQVIA Holdings Inc
IQV
LOCK|yv??vKwLOCK|?Kgd$43B
Waters Corp
WAT
LOCK|V!rB?JLOCK|qwQ$42B
IDEXX Laboratories Inc
IDXX
LOCK|Ws@q@#nLOCK|t?$41B
Illumina Inc
ILMN
LOCK|zr%R&!lLOCK|>L<xy$40B
Mettler-Toledo International Inc
MTD
LOCK|y?PvlQgjLOCK|N%N>h$30B
Quest Diagnostics Inc
DGX
LOCK|l%d?<v$LOCK|d@!%$26B
Labcorp Holdings Inc
LH
LOCK|>g#hRYBLOCK|Sb#@$25B

Sponsor Center